Furthermore, confocal imaging of fluorescent gliomas in vivo and ex vivo revealed that blockade of the beta-2-adrenergic receptors decreased glioma cell migration by 20% and reduced the disruption of the blood-brain barrier significantly (p < 0.001). The gene discussed is ADRB2; the disease is central nervous system cancer.